Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Amicus Therapeutics (FOLD) Tops Q1 EPS by 5c, Misses on Revenue
May 1, 2025 7:06 AM EDT(Updated - May 1, 2025 10:00 AM EDT)
Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of $0.03, $0.05 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $125.25 million versus the consensus estimate of $136.65 million.
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
... More